Table 2.
Calculations for evaluation of FIB-4 as a sole marker of fibrosis in the entire cohort
| FIB-4 ≥1.26 | FIB-4 <1.26 | Total | |
| Fibroscan ≥6 kPa | 10 (13%) | 9 (12%) | 19 (25%) |
| Fibroscan <6 kPa | 18 (24%) | 38 (51%) | 56 (75%) |
| Total | 28 (37%) | 47 (63%) | 75 (100%) |
Calculations for evaluation of FIB-4 as a sole marker of fibrosis in the entire cohort
| FIB-4 ≥1.26 | FIB-4 <1.26 | Total | |
| Fibroscan ≥6 kPa | 10 (13%) | 9 (12%) | 19 (25%) |
| Fibroscan <6 kPa | 18 (24%) | 38 (51%) | 56 (75%) |
| Total | 28 (37%) | 47 (63%) | 75 (100%) |